This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product. The purpose of this study is to assess, in a routine clinical environment at two centers the use of fabian-PRICO with noninvasive ventilation and its safety and performance at targeting and maintaining accurate SpO2 levels.
This is a randomized cross-over study. Subjects will be assigned to two, nominally 12-hour interventions, one with standard manual titration of FiO2 and the other with automated adjustment (PRICO). The order of these two interventions will be random. In addition to the ventilators data, basic demographics (i.e., gestational age, birth weight, age, weight at study) of the participating infants will be recorded in the eCRF. This study has no additional follow-up visits.
Study Type
OBSERVATIONAL
Enrollment
47
12 hours Automated PRICO FiO2 control
12 hours Manual PRICO FiO2 control
Buzzi Children's Hospital
Milan, Italy
Fondazione IRCCS San Gerardo dei Tintori
Monza, Italy
Target Range Compliance
Percentage of time that SpO2 is between 90-95% or above 95% when FiO2 = 21%
Time frame: 12 hours
Avoidance of SpO2 Extremes
Percentage of time that SpO2 is a) \<80% and b) \>98% when FiO2\>21%
Time frame: 12 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.